Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cranebio Co.,Ltd logo — New concept wearable feminine testers and infectious disease...

Cranebio Co.,Ltd

New concept wearable feminine testers and infectious disease self-testing kits based on the DNA origami technology

Founded 2021 Japan Japan 2 employees Series A Total: $250.00M Health Care

General Information

Company Name Cranebio Co.,Ltd
Founded Year 2021
Location Japan Japan +3
Employees 2
Industries Health Care
Funding Stage Series A
Social

Get notified when Cranebio Co.,Ltd moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cranebio Co.,Ltd

Cranebio Co.,Ltd is a Health Care startup, founded in 2021 in Japan. The company aims to revolutionize the market with its innovative wearable feminine testers and infectious disease self-testing kits. Leveraging DNA origami technology, Cranebio is developing femtech products for early detection of female-specific diseases and everyday health management for women. Their infectious disease self-testing kits cover ailments such as COVID-19 and HPV, while also offering rapid water inspection kits. The latest milestone for Cranebio was a significant ¥250.00M Series A investment secured on 04 October 2023. This round of funding saw participation from esteemed venture capital firms including Nippon Venture Capital, Axil Capital, and Akigin Capital Partners. The company's vision and robust technology indicate potential for growth and disruption in the health tech industry.

Taxonomy: femtech, DNA origami, infectious disease, self-testing kits, proteins detection, nucleic acid detection, wearable health care, genetic test kit, environmental test kit, COVID-19 testing, HPV testing, women's health, health management, early disease detection

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 3
Investor Investor
•••• •••• 		04 Oct 2023

Cranebio Co.,Ltd Alternatives & Competitors

Cranebio Co.,Ltd vs
UDoTest
UDoTest

Empowering proactive health with early disease detection through accessible self-sampling screening.

Non Equity Assistance
11-50 employees
B2B, Health Care
Cranebio Co.,Ltd vs
PathoScan
PathoScan Canada

Revolutionizing pathogen testing

Grant
3 employees
Agriculture, Information Technology
Cranebio Co.,Ltd vs
Early is Good
Early is Good United States

Ultra-Sensitive Multi-Omics Biomarker Detection To Transform The Future Healthcare

Seed
5 employees
Health Care

FAQ About Cranebio Co.,Ltd

New concept wearable feminine testers and infectious disease self-testing kits based on the DNA origami technology
Cranebio Co.,Ltd was founded in 2021.
Cranebio Co.,Ltd is headquartered in Japan.
Cranebio Co.,Ltd operates in the following industries: Health Care.
Cranebio Co.,Ltd has approximately 2 employees.
Cranebio Co.,Ltd has completed 1 funding round, raising a total of $250.00M. The latest funding stage is Series A.
Top alternatives and competitors to Cranebio Co.,Ltd include UDoTest, PathoScan, Early is Good, MD-Bio, Point of Care Nano-Technology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cranebio Co.,Ltd and UDoTest are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cranebio Co.,Ltd and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy